A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subject
ClinicalTrials.gov NCT05215418
Research payments
$3,424,695
Through program year 2023, $3,424,695 in research payments was reported against A Study of VI-0521 on Ambulatory Blood Pressure in Overweight or Obese Subject, across 229 payments, paid by VIVUS, Inc..
- Paid by
- VIVUS, Inc.
- ClinicalTrials.gov
- NCT05215418
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $3,424,695 | 229 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- William Smith New Orleans, LA Named on 44 payments
- Jeffrey Wayne Lincoln, CA Named on 25 payments
- Gary Dennis Plano, TX Named on 19 payments
- Terry Poling Wichita, KS Named on 18 payments
- Leonel Reyes San Antonio, TX Named on 15 payments
- Jeffrey Rosen Coral Gables, FL Named on 13 payments
- David Billmeier Port Orange, FL Named on 12 payments
- Hubert Reyes Evansville, IN Named on 11 payments
- Mark Adams London, KY Named on 9 payments
- Guillermo Somodevilla Miami, FL Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.